Universal Ibogaine Inc ( (TSE:IBO) ) has provided an announcement.
Universal Ibogaine Inc. has provided a bi-weekly update on its continued delay in filing audited financial statements for the year ended July 31, 2025, and related disclosures, which has led to a management cease trade order requiring ongoing status reports under Canadian securities rules. The company ...
HOLLYWOOD, FL – November 18, 2025 – Ibogaine By David Dardashti, a globally recognized leader in psychedelic-assisted therapies, today announced the five-year anniversary of the strategic integration of its specialized Ibogaine “reflection” treatment protocol. Following five years of meticulous data collection and patient monitoring, the clinic reports significant long-term success improvements for patients utilizing this smaller, ...
Playa del Carmen, Mexico – June 24, 2025 – Ibogaine by David Dardashti, a globally recognized leader in ibogaine treatment, proudly announces the grand opening of its second state-of-the-art clinic in the serene coastal city of Playa del Carmen, Mexico. This significant expansion is a direct response to the escalating demand for comprehensive ibogaine-assisted therapies ...
MIAMI, FL – June 20, 2025 – Ibogaine by David Dardashti, a pioneering leader in ibogaine-assisted therapy and led by visionary David Dardashti, today announced a groundbreaking collaboration with a Psychedelic University. This strategic partnership aims to establish robust internship opportunities for students passionate about contributing to the rapidly evolving psychedelic field, with initial networking ...
DENVER, CO – June 19, 2025 – Ibogaine by David Dardashti, a leading initiative in ibogaine research and advocacy, today commenced its participation in the highly anticipated Psychedelic Science Conference 2025 in Denver, Colorado. As the conference officially began its main programming today, June 18th, the presence of Ibogaine by David Dardashti marks a pivotal ...